United Kingdom· GB-APID-41537211000001100
Moxifloxacin 0.5% eye drops
A moxifloxacin product containing moxifloxacin, registered in United Kingdom by Brown & Burk UK Ltd. The same ATC class is registered in 12 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Moxifloxacin is registered in 12 of 19 countries.
Countries holding a registration under ATC S01AE07 (moxifloxacin), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Moxifloxacin · ATC S01AE07
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Moxifloxacin
- Manufacturer
- Brown & Burk UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- S01AE07
- ATC class
- Moxifloxacin
- Defined daily dose
- 0.57 mg, AT
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin05060124642222
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Moxifloxacin in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesMoxifloxacinHp Halden Pharma AS
- SpainABIMOX 5 MG/ML COLIRIO EN SOLUCIONTiedra Farmaceutica S.L.
- GermanyAvaloxBayer Vital Gmbh
- PolandFlomixaFarmak International Sp. z o.o.
- CzechiaAVELOXBayer AG, Leverkusen
- FinlandActiraBayer HealthCare AG
- SwitzerlandAvalox
- BelgiumAvelox 400 mgBayer
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Avelox, Moxifloxacin 1a Pharma
- Belgium · Avelox, Kanavig
- Bulgaria · Cimocinox, Moxifloxacin Kabi
- Cyprus · Avelox, Erelan
- Czechia · Avelox, Moxifloxacin Brown & Burk
- Germany · Avalox, Moxifloxacin 1 A Pharma
- Denmark · Moxifloxacin Accord, Moxifloxacin Fresenius Kabi
- Estonia · Avelox, Floxelan
- Spain · Abimox, Actira
- Finland · Moxifloxacin Fresenius Kabi, Moxifloxacin Krka
- France · Izilox, Moxifloxacine Arrow
- Greece · Avelox, Mikrobiel
- Croatia · Melvedok, Moksacin 5 Mg/Ml Kapi
- Hungary · Moxibiot, Moxifloxacin Anfarm
- Ireland · Moxifloxacin
- Iceland · Vigamox
- Italy · Avalox, Moxidrop
- Lithuania · Avelox, Ekara
- Luxembourg · Avelox, Kanavig
- Latvia · Avelox, Ekara
- Malta · Erelan, Moxifloxacin Anfarm
- Netherlands · Erelan, Moxifloxacin Hydrochloride Aurobindo
- Norway · Xinaflox
- Poland · Flomixa, Floxamic Neo
- Portugal · Avelox, Bluesar
- Romania · Avelox, Kimoks
- Sweden · Moxifloxacin Fresenius Kabi, Moxifloxacin Krka
- Slovenia · Kimoks, Moksifloksacin Kabi
- Slovakia · Avelox, Moloxin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aa006cec-2e9c-4966-9623-444400a98c96 GET /v1/drugs/aa006cec-2e9c-4966-9623-444400a98c96?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "41537211000001100",
"desc": "Moxifloxacin 0.5% eye drops (Brown & Burk UK Ltd)",
"form": "Eye drops",
"vpid": "18482711000001103",
"source": "dmd",
"vtm_id": "776831003",
"strength": "5 mg",
"substance": "Moxifloxacin",
"ingredient": "Moxifloxacin hydrochloride",
"supplier_code": "32392811000001109"
}See everything about moxifloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.